Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3774587
Max Phase: Preclinical
Molecular Formula: C35H40O11
Molecular Weight: 636.69
Molecule Type: Small molecule
Associated Items:
ID: ALA3774587
Max Phase: Preclinical
Molecular Formula: C35H40O11
Molecular Weight: 636.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)OC[C@@]12[C@@H](OC(C)=O)CC[C@@H](C)[C@]13OC(C)(C)[C@H]([C@@H](OC(=O)c1ccccc1)[C@H]2OC(=O)c1ccccc1)[C@H]3OC(C)=O
Standard InChI: InChI=1S/C35H40O11/c1-20-17-18-26(42-22(3)37)34(19-41-21(2)36)30(45-32(40)25-15-11-8-12-16-25)28(44-31(39)24-13-9-7-10-14-24)27-29(43-23(4)38)35(20,34)46-33(27,5)6/h7-16,20,26-30H,17-19H2,1-6H3/t20-,26+,27-,28-,29-,30-,34+,35-/m1/s1
Standard InChI Key: SYMROPCAWOJPQD-SPIKHJKTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 636.69 | Molecular Weight (Monoisotopic): 636.2571 | AlogP: 4.46 | #Rotatable Bonds: 8 |
Polar Surface Area: 140.73 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.68 | CX LogD: 4.68 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.30 | Np Likeness Score: 2.05 |
1. Núñez MJ, Jiménez IA, Mendoza CR, Chavez-Sifontes M, Martinez ML, Ichiishi E, Tokuda R, Tokuda H, Bazzocchi IL.. (2016) Dihydro-β-agarofuran sesquiterpenes from celastraceae species as anti-tumour-promoting agents: Structure-activity relationship., 111 [PMID:26854381] [10.1016/j.ejmech.2016.01.049] |
2. Wibowo M, Levrier C, Sadowski MC, Nelson CC, Wang Q, Holst J, Healy PC, Hofmann A, Davis RA.. (2016) Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularis., 79 (5): [PMID:27120798] [10.1021/acs.jnatprod.6b00190] |
Source(1):